Skip to content

Xencor XNCR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$163.1M+169%
Janux Therapeutics logo
Janux TherapeuticsJANX
$3.55M+293%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$14.02M+4,735%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.49M+377%
Absci Corporation logo
Absci CorporationABSI
$7.96M-80.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$378.17M

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+79.8%
Enterprise value$1.23B+58.6%
P/S11×+6.3×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's stock issuance proceeds?
Xencor (XNCR) reported stock issuance proceeds of $950K in Q1 2026.
How has Xencor's stock issuance proceeds changed year-over-year?
Xencor's stock issuance proceeds decreased by 68.1% year-over-year, from $2.97M to $950K.
What is the long-term trend for Xencor's stock issuance proceeds?
Over 4 years (2021 to 2025), Xencor's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $47.78M to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.